FinallyFoolin retweeted
AI has made building internal enterprise app much faster. Shipping them on governed data remains the hard part.
Snowflake App Runtime lets you build and run apps right where your data lives. New features in public preview: serverless compute, building in Snowsight with CoCo, and Python apps support.
Details: bit.ly/498cyOF
FinallyFoolin retweeted
$SPCX: Satya Nadella says Microsoft would rent SpaceX compute.
Asked at DealBook whether Musk is right about data centers in space:
"If he has SpaceX capacity that I can lease, I would lease it."
Same work, about a third of the price.
OpenAI's new GPT-6.2 Astra scored higher than the model it replaces on a test of long, multistep professional work, at $2.89 a task vs $8.99 (OpenAI's own numbers).
Basis says its average time on long-horizon accounting work fell 50%.
Cheaper agent work doesn't mean less AI. It means people hand it a lot more jobs. $NVDA
openai.com/index/introducing…
3
409
FinallyFoolin retweeted
Why did $NVDA cash decline sequentially for the first time in four years?
Nvidia spent $22B on buybacks and $6B on dividends (up from $243M a year ago) and is now deploying more cash than it generates.
That’s management saying the stock is dirt cheap.
FinallyFoolin retweeted
Colette’s excitement levels are somewhere between me at the dentist and me about to order a salad after my wife gave me a side eye for thinking burger. $NVDA
FinallyFoolin retweeted
$NVDA raises its revenue growth guidance for FY2028 to +75%YoY up from +70%YoY announced last quarter.
So much for the "AI is a bubble" narrative.
1st "bubble" in history where the leading business is trading ~10x Forward P/E and raising next year's guidance.
$5B to design medicines with AI.
Isomorphic Labs, the DeepMind spinout built on AlphaFold, just raised a $5B Series C, six months after a $2.1B round. It says its AI-designed programs have positive preclinical results in oncology and immunology, and the money goes toward getting candidates into clinical trials.
Preclinical isn't approval. But AI going from predicting protein shapes to running a real drug pipeline is the long-term story I care about. $GOOGL
techcrunch.com/2026/11/17/is…
3
317
Even the Fed now says AI is the biggest force in the financial system.
87% of contacts in its new survey named it, up from 50% in the spring.
And debt raised for AI compute topped $680B through October, about 5x all of 2023. Nobody borrows that kind of money for a fad.
The buildout is getting bigger, not slowing down. I'm still long $NVDA $MU.
federalreserve.gov/publicati…
2
434
PayPal took its internal AI assistant from 43% to 95% accuracy.
The model never changed. The context did.
They gave it their own definitions ("what counts as a new account?"), proven queries and playbooks. 1,000+ employee questions, ~1,600 hours saved in 10 weeks.
Models are getting commoditized. Context is king, and every company already owns theirs. $PYPL
tech.yahoo.com/ai/deals/arti…
2
597
FinallyFoolin retweeted
$AMZN AWS CEO: "AI inference isn't even at 1% of what it will become."
Good news for AI infrastructure companies.
43 days to get a diagnosis instead of 138.
Not a new drug. Not an AI replacing a doctor. A better way to get the right patients seen sooner.
This is the kind of AI story I want to see more of.
Vanderbilt tested an AI tool inside its medical records system. After a positive autoimmune screening test, it flagged higher-risk patients and alerted their doctors, offering a faster specialist appointment.
In the randomized trial, median time to diagnosis was 43 days with the alerts versus 138 without.
I think a lot of long-term AI value will look like this. Less waiting. Less work falling through the cracks. Useful predictions connected to something people can actually do about them.
One trial at one health system isn't proof it works everywhere. But people getting answers months earlier is a lot more interesting to me than another chatbot demo.
ep.jhu.edu/news/ai-tool-iden…
2
457
I think this is WAY underestimating it. What way way underestimating
Gartner predicts the average Fortune 500 enterprise will have more than 150,000 agents by 2028, up from fewer than 15 in 2025. Jacob Leverich on what that does to observability, at #SnowflakeExpedition.
"How will you make sure you can understand what's happening, and whether it's delivering value?" Telemetry belongs with the data the business owns.
Check out the key takeaways👇🧵
FinallyFoolin retweeted
The market is treating a Dem sweep as an existential threat to AI infrastructure. It’s not.
Data centres can (and already are) being built outside the US. Hyperscalers have major footprints and active expansions across Europe, Asia, the Middle East, Canada and LatAm. Power, speed of permitting and cost drive site selection more than pure US policy.
If domestic buildouts slow, capital will simply reallocate. Global AI compute demand doesn’t disappear because Northern Virginia or Texas gets harder to permit. Latency-sensitive training prefers concentrated clusters, but inference, regional capacity and a large share of workloads work fine abroad.
The nutty part is the indiscriminate selling of the whole growth stock complex. High-quality, FCF-positive AI names and infrastructure software companies with multi-year visibility are getting lumped in with pure high-beta, negative-FCF builders that actually do have financing and execution risk.
Policy friction in one country ≠ the end of the AI buildout.
International optionality is real.
FinallyFoolin retweeted
$ALAB
With Hulk smash numbers. Yes narrative winds are swirling but hard numbers don’t lie (at least for the next few Qs)
Again, no slow down in AI. We are still early
Very strong Q3 results and Q4 guidance from $ALAB ...
Q3 revs of $584.9M vs $548.5M est
Q3 revs up +49% QoQ
Q3 revs up +154% YoY
Q3 eps of $1.32 vs $1.19 est
Q3 eps up +65% QoQ
Q3 eps up +169% YoY
Q3 net income margin of 41.6% vs 38.3% in 2025 Q3
Guidance:
Q4 revs of $730-750M vs $655.7M est
Q4 revs guidance (midpoint) implies +27% QoQ
Q4 revs guidance (midpoint) implies +174% YoY (revenue growth is accelerating)
Q4 eps guidance of $1.62-1.66 vs $1.42 est
Q4 eps guidance (midpoint) implies +183% YoY growth (eps growth is accelerating)
Holy shit that Q4 guidance is strong!!!!
No idea how $ALAB is red/flat AH on this report, the stock should be up double digits.
Coming into this Q3 report... the sell side was looking for $6.15 of EPS over the next 12 months... I think $ALAB does at least $7.00 and perhaps $7.30 or better if we see more margin expansion
$ALAB got down to $215 AH, now trading at $232... if we use those lows... there's a chance the stock was trading at ~30x NTM EPS for one of the best growth stories in the entire market... literally trading at a NTM PEG ratio of 0.25x
1
18
5,453
FinallyFoolin retweeted
$ALAB delivered 😏
• Revenue $585M vs Est. $551M (+154% YoY)
• EPS $1.32 vs Est. $1.19
• Operating Income $262M vs Est. $238M
• Gross Margin 72% vs. Est. 60%
Q4 Guidance
• Revenue $740M vs Est. $656M (+174% YoY)
• EPS $1.64 vs Est. $1.42
• Operating Income $336M vs Est. $287M
• Gross Margin 72% vs. Est. 71%





















